All In Biotech

Drug Trial Radar · NCT05956418

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

A Prospective, Multi-centric, Open-labeled, Phase-IV Study to Assess Safety and Efficacy of LYFAQUIN™ (Centhaquine Citrate) as a Resuscitative Agent for Hypovolemic Shock to be Used as an Adjuvant to Standard Treatment of Shock

Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Aug 13, 2021

Primary completion

Nov 2026

Study completion Feb 2027

Sponsor

Lead sponsor
Pharmazz, Inc.Industry
Sponsor type
Industry
First posted
Jul 21, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-centric, open-labeled, phase-IV clinical study to evaluate the safety and efficacy of centhaquine citrate (LYFAQUIN™), a first-in-class drug for treating hypovolemic shock, a life-threatening condition caused by severe blood or fluid loss. Centhaquine has been found to be an effective resuscitative agent in rat, rabbit, and swine models of hemorrhagic shock. It has demonstrated the ability to decrease blood lactate levels, increase mean arterial pressure, enhance cardiac output, and reduce mortality rates. The increase in cardiac output during resuscitation is primarily attributed to an augmentation in stroke volume. Centhaquine exerts its effects by acting on the venous α2B-adrenergic receptors, which enhances venous return to the heart. Additionally, it produces arterial dilation by targeting central α2A-adrenergic receptors, thereby reducing sympathetic activity and systemic vascular resistance.

Conditions

  • Hypovolemic Shock

Interventions

  • CenthaquineDrug

    Centhaquine (LYFAQUIN™ or centhaquine citrate) is a novel, first-in-class, highly effective resuscitative agent for hypovolemic shock. Phase II results demonstrate highly significant efficacy in improving blood pressure (p\<0.0001), lactate levels (p=0.0012) and base-deficit (p\<0.0001). There was also improvement in reduction in use of vasopressors and reduced mortality. Similarly, results of phase III study confirmed the safety and efficacy of centhaquine as an adjuvant to standard of care for hypovolemic shock. Therefore, to assess safety of centhaquine in large population a phase IV study (post-authorization safety study) has been designed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients with adverse events (AEs) and serious adverse events (SAEs)Time frame: Up to 7 days

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • ACSR Government Medical College and Hospital

    Nellore, Andhra Pradesh, India · Recruiting

  • All India Institute of Medical Sciences (AIIMS)

    Raipur, Chhattisgarh, India · Recruiting

  • Aman Hospital

    Vadodara, Gujarat, India · Recruiting

  • New Era Hospital

    Nagpur, Maharashtra, India · Recruiting

  • Seven Star Hospital

    Nagpur, Maharashtra, India · Recruiting

  • Meditrina Hospital

    Nagpur, Maharashtra, India · Recruiting

  • Sri Guru Ram Das University of Health Sciences (SGRDH)

    Amritsar, Punjab, India · Recruiting

  • Dayanand Medical College & Hospital (DMCH)

    Ludhiana, Punjab, India · Recruiting

  • Christian Medical College and Hospital (CMC)

    Ludhiana, Punjab, India · Recruiting

  • Government Medical College

    Kota, Rajasthan, India · Recruiting

  • KG Hospital

    Coimbatore, Tamil Nadu, India · Recruiting

  • Pushpanjali Hospital

    Agra, Uttar Pradesh, India · Recruiting

  • Maharani Laxmi Bai Medical College (MLBMC)

    Jhānsi, Uttar Pradesh, India · Recruiting

  • Nirmal Hospital

    Jhānsi, Uttar Pradesh, India · Recruiting

  • Ganesh Shankar Vidyarthi Memorial Medical College (GSVM)

    Kanpur, Uttar Pradesh, India · Recruiting

  • Janta Hospital

    Varanasi, Uttar Pradesh, India · Recruiting

  • IPGMER & SSKM Hospital

    Kolkata, West Bengal, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.